- Refractory Hepatic Hydrothorax in Chronic Hepatitis C Controlled by Direct-acting Antivirals
-
Kim MH, Kim DK, Eun HS, Rou WS, Kim SH, Lee BS
- KMID: 2471149
- Korean J Gastroenterol.
- 2020 Feb;75(2):98-102.
- doi: 10.4166/kjg.2020.75.2.98
Hepatic hydrothorax is a transudative pleural effusion that complicates advanced liver cirrhosis. Patients refractory to medical treatment plus salt restriction and diuretics are considered to have refractory hepatic hydrothorax and... -
- CITED
-
- Close
- SHARE
-
- Close
- An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection
-
Lee YJ, Heo J, Kim DY, Chung WJ, Tak WY, Kim YJ, Paik SW, Sim E, Kulasingam S, Talwani R, Haber B, Hwang P
- KMID: 2467250
- Clin Mol Hepatol.
- 2019 Dec;25(4):400-407.
- doi: 10.3350/cmh.2019.0006
BACKGROUND/AIMS: In the Republic of Korea, an estimated 231,000 individuals have chronic hepatitis C virus (HCV) infection. The aim of the present analysis was to evaluate the safety and efficacy... -
- CITED
-
- Close
- SHARE
-
- Close
- Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failure
-
Parigi TL, Torres MC, Aghemo A
- KMID: 2467245
- Clin Mol Hepatol.
- 2019 Dec;25(4):360-365.
- doi: 10.3350/cmh.2019.0022
Despite the high efficacy of direct acting antivirals (DAAs) not all patients successfully clear hepatitis C virus infection, in fact, approximately 1–3% fail to reach a sustained virological response 12... -
- CITED
-
- Close
- SHARE
-
- Close
- The Management Outcome and Expansion Strategy for Treatment of Hepatitis C Virus Infection among Persons Affected with Leprosy
-
Lee MW, Park HC
- KMID: 2466492
- Korean Lepr Bull.
- 2019 Dec;52(1):51-54.
- doi: 10.33161/klb.2019.52.1.51
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Multimodality Imaging Features of Cardiac Fungal Infection: A Case Report
-
Talib N, Mohammed Y, Abas SI, Ramli KA
- KMID: 2465784
- Cardiovasc Imaging Asia.
- 2019 Oct;3(4):125-128.
- doi: 10.22468/cvia.2019.00122
We present a 38-year-old man with hepatitis C and history of intravenous drug use who presented with fever and hemoptysis. Initial chest CT showed bronchiectasis with an intracavitary lesion consistent... -
- CITED
-
- Close
- SHARE
-
- Close
- What is the Long-term Benefit of Direct-acting Antiviral Therapy in Chronic Hepatitis C?
-
Kim JW
- KMID: 2460926
- J Korean Med Sci.
- 2019 Oct;34(41):e277.
- doi: 10.3346/jkms.2019.34.e277
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Durability of Sustained Virologic Response and Improvement of Fibrosis Markers after Daclatasvir and Asunaprevir Treatment in Genotype 1b Hepatitis C Virus-Infected Patients: a Real Life and Multicenter Study
-
Shin SK, Lee JW, Ra H, Kwon OS, Shin JB, Jin YJ, Lee S, Han KJ, Kim YN, Kim TH, Kim YS, Kim JH
- KMID: 2460924
- J Korean Med Sci.
- 2019 Oct;34(41):e264.
- doi: 10.3346/jkms.2019.34.e264
BACKGROUND: The long-term data with direct acting antiviral agents were rare. This study investigated the durability of a sustained virologic response (SVR) and the improvement of fibrosis after daclatasvir and... -
- CITED
-
- Close
- SHARE
-
- Close
- Are there differences in risk factors, microbial aspects, and prognosis of cellulitis between compensated and decompensated hepatitis C virus-related cirrhosis?
-
Hassan EA, Rehim AS, Abdel-Malek MO, Ahmed AO, Abbas NM
- KMID: 2459793
- Clin Mol Hepatol.
- 2019 Sep;25(3):317-325.
- doi: 10.3350/cmh.2018.0097
BACKGROUND/AIMS: Cellulitis is a common infection in patients with liver cirrhosis. We aimed to compare risk factors, microbial aspects, and outcomes of cellulitis in compensated and decompensated hepatitis C virus... -
- CITED
-
- Close
- SHARE
-
- Close
- Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio
-
Wong L, Bozhilov K, Hernandez , Kwee S, Chan O, Ellis L, LeMarchand L
- KMID: 2459792
- Clin Mol Hepatol.
- 2019 Sep;25(3):305-316.
- doi: 10.3350/cmh.2019.0004
BACKGROUND/AIMS: Inflammation-based scores, such as the neutrophil-to-lymphocyte ratio (NLR), have been associated with prognosis in hepatocellular carcinoma (HCC); but variable cut-off values and potential lack of specificity have limited the... -
- CITED
-
- Close
- SHARE
-
- Close
- Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C
-
Na SK, Song BC
- KMID: 2459785
- Clin Mol Hepatol.
- 2019 Sep;25(3):234-244.
- doi: 10.3350/cmh.2018.0108
Hepatitis C virus (HCV) infection is a major risk factor for liver cirrhosis and hepatocellular carcinoma (HCC), and is a leading cause of liver-related deaths worldwide. Recently available direct-acting antiviral... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the Clinical Characteristics and Outcomes between Leprosy-Affected Persons in Sorokdo and the General Population Affected by Chronic Hepatitis C in Korea
-
Ahn YH, Park H, Lee MJ, Kim DH, Cho SB, Cho E, Jun CH, Choi SK
- KMID: 2458512
- Gut Liver.
- 2019 Sep;13(5):549-556.
- doi: 10.5009/gnl18432
BACKGROUND/AIMS: Patients with Hansen’s disease are the most vulnerable to hepatitis C. However, no data on the treatment efficacy of direct-acting antiviral agents (DAAs) are available in this group. Therefore,... -
- CITED
-
- Close
- SHARE
-
- Close
- Platelet count is associated with sustained virological response rates in treatments for chronic hepatitis C
-
Jun BG, Park EJ, Lee WC, Jang JY, Jeong SW, Kim YD, Cheon GJ, Cho YS, Lee SH, Kim HS, Lee YN, Kim SG, Kim YS, Kim BS
- KMID: 2457022
- Korean J Intern Med.
- 2019 Sep;34(5):989-997.
- doi: 10.3904/kjim.2017.322
BACKGROUND/AIMS: This study was conducted to clarify the sustained virological response (SVR) prediction ability of baseline and treatment-related factors in patients with chronic hepatitis C virus (HCV) infection. METHODS: This retrospective... -
- CITED
-
- Close
- SHARE
-
- Close
- Prediction and Staging of Hepatic Fibrosis in Children with Hepatitis C Virus: A Machine Learning Approach
-
Barakat NH, Barakat SH, Ahmed N
- KMID: 2457469
- Healthc Inform Res.
- 2019 Jul;25(3):173-181.
- doi: 10.4258/hir.2019.25.3.173
OBJECTIVES: The aim of this study is to develop an intelligent diagnostic system utilizing machine learning for data cleansing, then build an intelligent model and obtain new cutoff values for... -
- CITED
-
- Close
- SHARE
-
- Close
- Daclatasvir and asunaprevir combination therapy for patients with chronic hepatitis C virus genotype 1b infection in real world
-
Oh JY, Kim BS, Lee CH, Song JE, Lee HJ, Park JG, Hwang JS, Chung WJ, Jang BK, Kweon YO, Tak WY, Park SY, Jang SY, Suh JI, Kwak SG
- KMID: 2457309
- Korean J Intern Med.
- 2019 Jul;34(4):794-801.
- doi: 10.3904/kjim.2017.368
BACKGROUND/AIMS: Previous studies have reported a high rate of sustained virologic response (SVR) and a low rate of serious adverse events with the use of daclatasvir (DCV) and asunaprevir (ASV)... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of Noninvasive Liver Fibrosis Blood Markers in Patients with Chronic Hepatitis B and Hepatitis C
-
Lee JH, Cho J, Kim J, Uh Y, Youn KJ
- KMID: 2450840
- Lab Med Online.
- 2019 Jul;9(3):153-160.
- doi: 10.3343/lmo.2019.9.3.153
BACKGROUND: Liver fibrosis evaluation is an important issue in chronic liver disease patients. We aimed to develop noninvasive liver fibrosis biomarkers based on transient elastography (TE, FibroScan®) through retrospective review... -
- CITED
-
- Close
- SHARE
-
- Close
- Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
-
Huang CF, Yu ML
- KMID: 2451919
- Clin Mol Hepatol.
- 2019 Jun;25(2):168-171.
- doi: 10.3350/cmh.2018.1014
During the clinical trial development of directly acting antivirals (DAAs), evidence regarding the treatment efficacy in chronic hepatitis C patients with hepatocellular carcinoma (HCC) was scarce because these patients have... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection
-
Sato S, Moriya K, Furukawa M, Saikawa S, Namisaki T, Kitade M, Kawaratani H, Kaji K, Takaya H, Shimozato , Sawada Y, Seki K, Kitagawa K, Akahane T, Mitoro A, Okura Y, Yamao J, Yoshiji H
- KMID: 2447252
- Clin Mol Hepatol.
- 2019 Mar;25(1):65-73.
- doi: 10.3350/cmh.2018.0070
BACKGROUND/AIMS: L-carnitine not only alleviates hyperammonemia and reduces muscle cramps in patients with liver cirrhosis, but also improves anemia in patients with chronic hepatitis and renal dysfunction. This study prospectively... -
- CITED
-
- Close
- SHARE
-
- Close
- Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
-
Mölleken , Ahrens M, Schlosser , Dietz J, Eisenacher M, Meyer HE, Schmiegel , Holmskov U, Sarrazin C, Sorensen G, Sitek B, Bracht T
- KMID: 2447250
- Clin Mol Hepatol.
- 2019 Mar;25(1):42-51.
- doi: 10.3350/cmh.2018.0029
BACKGROUND/AIMS: An estimated 80 million people worldwide are infected with viremic hepatitis C virus (HCV). Even after eradication of HCV with direct acting antivirals (DAAs), hepatic fibrosis remains a risk... -
- CITED
-
- Close
- SHARE
-
- Close
- Biomarker microfibril-associated glycoprotein 4 for non-invasive diagnosis and therapeutic evaluation of hepatic fibrosis in patients with hepatitis C
-
Eom YW, Baik SK
- KMID: 2447248
- Clin Mol Hepatol.
- 2019 Mar;25(1):37-39.
- doi: 10.3350/cmh.2018.1011
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Discussion on critical points for a tailored therapy to cure hepatitis C virus infection
-
Marascio N, Quirino A, Barreca GS, Galati L, Costa C, Pisani V, Mazzitelli M, Matera G, Liberto MC, Focà A, Torti C
- KMID: 2447247
- Clin Mol Hepatol.
- 2019 Mar;25(1):30-36.
- doi: 10.3350/cmh.2018.0061
Hepatitis C virus (HCV) infects around 71 million people worldwide and in 2018 it is still a major health problem. Since 2011, anti-HCV therapy with availability of direct-acting antiviral drugs... -
- CITED
-
- Close
- SHARE
-
- Close
